Merck Sues To Nix Mylan's Plans For Diabetes Generic
Merck & Co. Inc. filed a lawsuit on Thursday in West Virginia federal court seeking to block competing drug maker Mylan NV from moving ahead with plans to sell generic versions...To view the full article, register now.
Already a subscriber? Click here to view full article